TNF and cancer: Additionally, Cho et al. found that M1 macrophages could secret TNF-α, and that the implementation of TNF-α inhibitor, TPCK, could suppress ovarian cancer invasion [85], indicating that M1/M2 macrophage-derived TNF-α promoting cancer invasion is a common event in tumor progression.